Myomo MYO
NYSE MYO
$1.73 -0.01 (-0.57%)
At close: Aug 21, 2026 · 4:00 PM EDT

Myomo (MYO) Preferred Stock Liabilities (2016)

Myomo's (MYO) quarterly Preferred Stock Liabilities came in at $12.7 million in Q4 2016.

Myomo (MYO) Preferred Stock Liabilities (2016) Analysis & Trends

Myomo (MYO) has 1 years of Preferred Stock Liabilities data on file, last reported at $12.7 million in Q4 2016.

  • Quarterly Preferred Stock Liabilities changed N/A year-over-year to $12.7 million in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $12.7 million (changed N/A YoY) and the FY2016 annual result came in at $12.7 million, changed N/A from the prior year.
  • Preferred Stock Liabilities was little changed at $12.7 million in Q4 2016.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $12.7 million in Q4 2016 to a low of $12.7 million in Q4 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn -
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn -
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn -
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn -
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn -
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn -
10 Myomo 67.26 Mn 48.29 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2016 12.67 Mn